← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2006Last known activity
Mar 31, 2025
Timeline
1990s
- Jun 1, 1994
Can-Fite BioPharma— Founded
Drugs by trial phase (4 distinct, 21 trials)
Phase 3 (4 own, 0 via acquisition)
Indications
Studied for
- Arthritis
- Arthritis, Rheumatoid
- Carcinoma
- Carcinoma, Hepatocellular
- Coronavirus Infections
- Dry Eye Syndromes
- Eye Diseases
- Fatty Liver
- Glaucoma
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- Hypertension
- Keratoconjunctivitis
- Keratoconjunctivitis Sicca
- Liver Diseases
- Non-alcoholic Fatty Liver Disease
- Ocular Hypertension
- Osteoarthritis
- Osteoarthritis, Knee
- Pars Planitis
- Psoriasis
- Severe Acute Respiratory Syndrome
- Uveitis
- Uveitis, Intermediate
- Uveitis, Posterior
Recent trials (32)
- NCT06643260Lead sponsorPhase 3Mar 31, 2025
- NCT06387342OfficialPhase 2Dec 15, 2024
- NCT06387342Lead sponsorPhase 2Dec 15, 2024
- NCT05201404Lead sponsorPhase 3Jan 31, 2023
- NCT04697810Lead sponsorPhase 2Aug 15, 2021
- NCT04333472Lead sponsorPhase 2Apr 6, 2020
- NCT04333472Study directorPhase 2Apr 6, 2020
- NCT03168256Lead sponsorPhase 3Feb 1, 2018
- NCT02927314Lead sponsorPhase 2Feb 1, 2017
- NCT02927314Study directorPhase 2Feb 1, 2017
- NCT01905124Lead sponsorPhase 2Jan 1, 2017
- NCT00837291Lead sponsorPhase 2Nov 1, 2016
- NCT00837291Study directorPhase 2Nov 1, 2016
- NCT02647762Lead sponsorPhase 3Sep 1, 2016
- NCT02647762Study directorPhase 3Sep 1, 2016
Details
- Founded
- Petah-Tikva, IL Jun 1, 1994
- Last known activity
- Mar 31, 2025